Kinaxis Inc. (TSE:KXS – Get Free Report) Director Gillian (Jill) Denham sold 15,968 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of C$171.36, for a total transaction of C$2,736,276.48. Following the transaction, the director owned 18,732 shares in the company, valued at C$3,209,915.52. The trade was a 46.02% decrease in their position.
Kinaxis Stock Performance
Shares of TSE:KXS traded down C$1.52 on Wednesday, hitting C$169.22. 65,898 shares of the company were exchanged, compared to its average volume of 122,506. Kinaxis Inc. has a 1-year low of C$117.22 and a 1-year high of C$201.00. The stock’s 50 day moving average price is C$158.22 and its 200 day moving average price is C$145.34. The company has a current ratio of 1.88, a quick ratio of 2.29 and a debt-to-equity ratio of 11.14. The firm has a market capitalization of C$4.60 billion, a P/E ratio of 55.30, a price-to-earnings-growth ratio of 3.60 and a beta of 0.76.
Kinaxis (TSE:KXS – Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported C$1.08 earnings per share (EPS) for the quarter. The firm had revenue of C$230.64 million for the quarter. Kinaxis had a return on equity of 20.88% and a net margin of 14.40%. Sell-side analysts predict that Kinaxis Inc. will post 4.2526231 EPS for the current year.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on Kinaxis
Kinaxis Company Profile
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
Recommended Stories
- Five stocks we like better than Kinaxis
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
